Although three mutations in the PALB2-binding domain (G25R, W31C and W31R) that disrupt the interaction between the two proteins are linked to breast cancer development, their precise disease association remains uncertain due to limited family-linkage data [21]. Here, PALB2 is linked to breast cancer.